Loading
Endpoint Clinical
Endpoint Clinical is a global leader in randomization and trial supply management (RTSM) solutions, specializing in interactive response technology (IRT®) for clinical trials in the life sciences and pharmaceutical industries. Founded in 2009 and based in Raleigh, North Carolina, with additional operations in Wakefield, Massachusetts, the company serves clients across the US, EU, and Asia. As of June 2024, Endpoint Clinical operates independently under Arsenal Capital Partners after being acquired. The company offers a range of services through its proprietary PULSE® platform, a cloud-based IRT system that supports patient randomization, site management, drug supply management, and electronic patient-reported outcomes (ePRO). The platform can be deployed quickly, allowing non-technical users to customize solutions in as little as four weeks. Additionally, Endpoint Clinical provides clinical supplies management technology through its DRIVE tool, along with professional services for inventory and RTSM consulting. The company supports over 2,000 studies globally, managing more than 650,000 patients and 90,000 sites.
Funding
Every round, secondary, debt facility or acquisition involving Endpoint Clinical that Lounge tracks, newest first.
No rounds recorded yet.
Paid members see the full deals desk — every AI round and exit, filterable by type, sector and country, with investors and reported ARR, plus CSV exports. Developer membership is $9/mo.
See plans →Log inKey numbers
—
0
—
$7M